Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung Cancer

NCT00575393 PHASE1 COMPLETED

RATIONALE: Gold sodium thiomalate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase I trial is studying the side effects and best dose of gold sodium thiomalate in treating patients with advanced non-small cell lung cancer.

Details

Lead sponsor	Mayo Clinic
Phase	PHASE1
Status	COMPLETED
Enrolment	17
Start date	Thu Jan 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Lung Cancer

Interventions

• gold sodium thiomalate
• gene expression analysis
• fluorine F 18 fluorothymidine
• mass spectrometry
• pharmacological study

Countries

United States